trial myxoma: a ten years experience at the NICVD

ABSTRACT

A trial myxoma is a rare disease. This is a ten-year retrospective study carried out between January 1991 and December 2000. Our goals were to find out the incidence and long term results of this disease. 52 patients were identified with this condition during this period. The majority of patients were females 41 [78.8 percent] compared to males 11 [21.2 percent]. The mean age was 35 years [28-50 years]. The diagnosis was confirmed at 2D echocardiography surgical treatment entailed excision of the myxoma under CPB. All specimens were sent for histology. Complete excision of the myxoma was achieved in all patients. The incidence of malignancy was very small i.e. 2 patients [3.84 percent]. The hospital mortality was 5.8 percent. The commonest complication was bleeding 11. 5 percent. There was no recurrence at 2 years follow up. Atrial myxoma is a curable disease. Once treated surgically, it has excellent long term prognosis